2026-10-15T10:40:19Z https://data.mendeley.com/oai

oai:data.mendeley.com/kfzyfrfc7m.1 2023-10-30T07:24:42Z

Yang, Xing-yu Mendeley Supplemental Figure 1 Mendeley Data Supplemental material for reviewers only. Comparison of reduced Psoriasis Area Severity Index (PASI) scores with ixekizumab monoclonal antibody monotherapy, secukinumab monoclonal antibody monotherapy, and tofacitinib combination therapy at various time points. Psoriasis Dataset doi:10.17632/kfzyfrfc7m.1 oai:data.mendeley.com/kfzyfrfc7m.1 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/kfzyfrfc7m 2023-10-30T07:24:42Z